Keith Wheatley

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Hodgkin Lymphoma

Top Venues

British journal of haematology

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

David R W Jayne, Michael Walsh, Peter A Merkel, Chen Au Peh, Wladimir M Szpirt, Xavier Puechal, Shouichi Fujimoto, Carmel M Hawley, Nader A Khalidi, Rachel Jones, Oliver Flossmann, Ron Wald, Louis-Philippe Girard, Adeera Levin, Gina Gregorini, Lorraine Harper, William Clark, Christian Pagnoux, Ulrich Specks, Lucy Smyth, Toshiko Ito-Ihara, Janak R de Zoysa, Biljana Brezina, Andrea Mazzetti, Carol A McAlear, Donna Reidlinger, Samir Mehta, Natalie J Ives, Elizabeth A Brettell, Hugh Jarrett, Keith Wheatley, Elizabeth Broadhurst, Alina Casian, Charles D Pusey
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT. Health technology assessment (Winchester, England) 26 (38) (2022)
Adam Gibb, Sarah J Pirrie, Kim M Linton, Victoria Warbey, Kathryn Paterson, Andrew John Davies, Graham P Collins, Tobias Menne, Pamela McKay, Paul A Fields, Fiona M Miall, Eszter Nagy, Keith Wheatley, Rachel Reed, Ivona Baricevic-Jones, Sally F Barrington, John Radford
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY). British journal of haematology 193 (1) (2020)